CRO Valuation Multiples

Healthcare & Life Sciences
Pharma Services Valuation Multiples: CRO, CDMO, EBITDA, and Backlog
ByAuxo Capital AdvisorsJune 19, 2026
A buyer-focused guide to pharma services valuation multiples covering CRO and CDMO pricing, normalized EBITDA, backlog quality, utilization, margins, quality systems, capital needs, buyer fit, deal structure, and seller proceeds.
Read More Pharma Services Valuation Multiples: CRO, CDMO, EBITDA, and Backlog
Healthcare & Life Sciences
CRO M&A: How Buyers Underwrite Contract Research Organizations
ByAuxo Capital AdvisorsJune 19, 2026
A buyer-focused guide to CRO M&A valuation, showing how acquirers translate backlog quality, project visibility, sponsor concentration, scientific talent, and diligence findings into multiples, deal terms, and purchase price adjustments.
Read More CRO M&A: How Buyers Underwrite Contract Research Organizations